XML 51 R38.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Gross Premiums Written by Line of Business
The table below provides information about the Company’s reportable segments, including the reconciliation to net income as reported under U.S. GAAP. Comparatives have been recast to conform with the current reportable segments.
Three months ended March 31, 2025:
Open MarketInnovationsCorporateTotal Consolidated
Gross premiums written$220,709 $27,466 $(230)$247,945 
Net premiums written$195,609 $23,971 $(183)$219,397 
Net premiums earned$149,641 $19,005 $(183)$168,463 
Net loss and LAE incurred
(112,763)(10,346)225 (122,884)
Acquisition costs(40,881)(6,033)48 (46,866)
Other underwriting expenses(4,797)(1,561)— (6,358)
Deposit interest expense, net
(149)— — (149)
Underwriting income (loss)(8,949)1,065 90 (7,794)
Reconciliation to income before income taxes:
Net investment income5,771 448 2,068 8,287 
Corporate and other expenses— (572)(4,100)(4,672)
Income from investment in Solasglas32,197 32,197 
Foreign exchange gains (losses)4,355 4,355 
Interest expense(1,464)(1,464)
Income (loss) before income taxes
$(3,178)$941 $33,146 $30,909 
Additional information:
Net loss and LAE incurred:
  Attritional losses$(80,852)$(10,913)$114 $(91,651)
  CAT losses(27,015)— — (27,015)
  Prior year adverse (favorable) loss development(4,896)567 111 (4,218)
Total net loss and LAE incurred$(112,763)$(10,346)$225 $(122,884)
Total allocated assets (1)
$459,549 $145,402 $1,547,145 $2,152,096 

(1) The Company does not allocate assets to reporting segments, with the exception of restricted cash used to collateralized certain reinsurance transactions, including FAL, and Innovations-related private investments.
Three months ended March 31, 2024:
Open MarketInnovationsCorporateTotal Consolidated
Gross premiums written$187,061 $30,068 $129 $217,258 
Net premiums written$167,716 $26,244 $117 $194,077 
Net premiums earned$131,610 $20,197 $9,729 $161,536 
Net loss and LAE incurred
(86,700)(13,127)(9,499)(109,326)
Acquisition costs(33,579)(6,053)(1,978)(41,610)
Other underwriting expenses(5,478)(861)— (6,339)
Deposit interest expense, net
(876)— — (876)
Underwriting income (loss)4,977 156 (1,748)3,385 
Reconciliation to income before income taxes:
Net investment income12,616 (183)745 13,178 
Corporate and other expenses— (590)(3,785)(4,375)
Income from investment in Solasglas18,248 18,248 
Foreign exchange gains (losses)(1,649)(1,649)
Interest expense(1,249)(1,249)
Income (loss) before income taxes$17,593 $(617)$10,562 $27,538 
Additional information:
Net loss and LAE incurred:
  Attritional losses$(72,790)$(13,128)$(5,570)$(91,488)
  CAT losses(12,437)— — (12,437)
  Prior year adverse (favorable) loss development(1,473)(3,929)(5,401)
Total net loss and LAE incurred$(86,700)$(13,127)$(9,499)$(109,326)
Total allocated assets (1)
$479,820 $92,939 $1,304,210 $1,876,969 
(1) The Company does not allocate assets to reporting segments, with the exception of restricted cash used to collateralized certain reinsurance transactions, including FAL, and Innovations-related private investments.